Tracking sludge flow for better wastewater treatment and more biogas
Monitoring thermal treatment performance by tracking how sewage sludge flows A new way of tracking how sewage sludge flows during thermal treatment could help engineers...
Monitoring thermal treatment performance by tracking how sewage sludge flows A new way of tracking how sewage sludge flows during thermal treatment could help engineers...
Copper-based alternative for next-generation electronicsCredit: Kiyoshi Kanie Japanese scientists have developed a technique to transform a copper-based substance into a material that mimics properties of...
Credit: Cazaux et al., 2019 In a study that will be published April 1 in the Journal of Experimental Medicine, researchers from the Institut Pasteur...
Goethe University secures three ERC Advanced Grants, a total of € 7.7 million for five yearsCredit: Uwe Dettmar "For the first time, Goethe University has...
New studies led by University of North Carolina Lineberger Comprehensive Cancer Center researchers explore biological mechanisms behind obesity and its link with cancer. Research findings...
DC joins 37 states in passing Breast Density Screening and Notification Act to address little known risk factor for breast cancerCredit: Brem Foundation Silver Spring,...
ATLANTA -- Treatment with the FLT3-targeted therapeutic gilteritinib (Xospata) improved survival for patients with relapsed or refractory acute myeloid leukemia (AML) harboring a FLT3 mutation...
ATLANTA -- Vaccination with as few as four tumor antigens generated antigen-specific responses, reduced intestinal tumors, and improved survival in a mouse model of Lynch...
ATLANTA -- The investigational therapeutic umbralisib, which targets the molecule PI3K-delta, was well tolerated and highly active in patients with relapsed/refractory marginal zone lymphoma, according...
ATLANTA -- The anti-PD-1 monoclonal antibody pembrolizumab (Keytruda) showed promising antitumor activity with durable responses in patients with pretreated, advanced small cell lung cancer (SCLC),...
Data presented at AACR Annual Meeting on recently approved drug that targets common mutation in AML ATLANTA - An inhibitor drug that targets a specific...
MD Anderson Phase II trial shows drug well tolerated with high response rates for marginal zone lymphomaCredit: MD Anderson Cancer Center A study at The...
Obstructive sleep apnea and short sleep duration have distinct clinical impacts; clinicians should avoid a 'one-size-fits-all' approach through proper diagnosis to prevent and treat sleep...
Circulation Journal Report DALLAS, April 1, 2019 -- A Swedish review of out-of-hospital cardiac arrest data shows rates of bystander CPR nearly doubled; compression-only (or...
Credit: Tae Hyun Kim ANN ARBOR, Michigan -- A prototype wearable device, tested in animal models, can continuously collect live cancer cells directly from a...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.